Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Other Working Capital Changes: 2011-2024

Historic Other Working Capital Changes for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to -$732,000.

  • Niagen Bioscience's Other Working Capital Changes rose 43.31% to -$233,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 million, marking a year-over-year decrease of 84.56%. This contributed to the annual value of -$732,000 for FY2024, which is 13.66% down from last year.
  • Per Niagen Bioscience's latest filing, its Other Working Capital Changes stood at -$732,000 for FY2024, which was down 13.66% from -$644,000 recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Other Working Capital Changes ranged from a high of $872,000 in FY2022 and a low of -$732,000 during FY2024.
  • For the 3-year period, Niagen Bioscience's Other Working Capital Changes averaged around -$168,000, with its median value being -$644,000 (2023).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 42.61% in 2021, then tumbled by 173.85% in 2023.
  • Niagen Bioscience's Other Working Capital Changes (Yearly) stood at $568,000 in 2020, then surged by 42.61% to $810,000 in 2021, then rose by 7.65% to $872,000 in 2022, then slumped by 173.85% to -$644,000 in 2023, then fell by 13.66% to -$732,000 in 2024.